AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
3.360
+0.220 (7.01%)
At close: Jan 2, 2026, 4:00 PM EST
3.350
-0.010 (-0.30%)
After-hours: Jan 2, 2026, 6:21 PM EST
AC Immune Market Cap
AC Immune has a market cap or net worth of $332.45 million as of January 2, 2026. Its market cap has increased by 12.89% in one year.
Market Cap
332.45M
Enterprise Value
202.26M
1-Year Change
12.89%
Ranking
Category
Stock Price
$3.36
Market Cap Chart
Since September 23, 2016, AC Immune's market cap has decreased from $867.50M to $332.45M, a decrease of -61.68%. That is a compound annual growth rate of -9.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 316.80M | 17.51% |
| Dec 31, 2024 | 269.60M | -36.36% |
| Dec 29, 2023 | 423.60M | 145.85% |
| Dec 30, 2022 | 172.30M | -52.25% |
| Dec 31, 2021 | 360.80M | -2.88% |
| Dec 31, 2020 | 371.50M | -35.46% |
| Dec 31, 2019 | 575.60M | 6.20% |
| Dec 31, 2018 | 542.00M | -25.42% |
| Dec 29, 2017 | 726.70M | 1.07% |
| Dec 30, 2016 | 719.00M | -17.12% |
| Sep 23, 2016 | 867.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.25B |
| Johnson & Johnson | 498.60B |
| AbbVie | 403.83B |
| UnitedHealth Group | 299.03B |
| AstraZeneca | 287.81B |
| Novartis AG | 266.00B |
| Merck & Co. | 261.26B |
| Novo Nordisk | 227.63B |